
American women are delaying gynecological checkups—and over half are doing so out of fear or discomfort, finds a new Harris Poll.
The survey of 1,100 women was conducted in November on behalf of global medical technology company Becton, Dickinson & Company (BD), which recently had its in-office self-collection HPV testing kit, the BD Onclarity HPV Assay, approved by the U.S. Food and Drug Administration.